Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
23.00
-0.37 (-1.58%)
At close: Apr 28, 2026, 4:00 PM EDT
23.31
+0.31 (1.35%)
After-hours: Apr 28, 2026, 6:48 PM EDT
AAPG Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for AAPG stock have an average target of 48.4, with a low estimate of 45 and a high estimate of 51. The average target predicts an increase of 110.43% from the current stock price of 23.00.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for AAPG stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 2 | 3 | 3 | 3 | 3 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 5 | 5 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Reiterates $48 | Strong Buy | Reiterates | $48 | +108.70% | Apr 13, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $48 | Strong Buy | Reiterates | $48 | +108.70% | Mar 26, 2026 |
| BTIG | BTIG | Strong Buy Initiates $48 | Strong Buy | Initiates | $48 | +108.70% | Mar 12, 2026 |
| Oppenheimer | Oppenheimer | Buy Initiates $45 | Buy | Initiates | $45 | +95.65% | Dec 4, 2025 |
| Truist Securities | Truist Securities | Strong Buy Initiates $51 | Strong Buy | Initiates | $51 | +121.74% | Nov 24, 2025 |
Financial Forecast
Revenue This Year
2.24B
from 574.12M
Increased by 290.34%
Revenue Next Year
1.88B
from 2.24B
Decreased by -16.20%
EPS This Year
1.21
from -3.49
EPS Next Year
-0.35
from 1.21
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 3.3B | 3.2B | ||||||
| Avg | 2.2B | 1.9B | ||||||
| Low | 829.1M | 1.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 477.2% | 41.5% | ||||||
| Avg | 290.3% | -16.2% | ||||||
| Low | 44.4% | -55.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 4.84 | 3.44 | |||
| Avg | 1.21 | -0.35 | |||
| Low | -2.98 | -1.73 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | 183.9% | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.